Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: Effect of a 6 month regime intervention

Acta Gastro-Enterologica Belgica

Volumn 70, Issue 3, 2007, Pages 253-259

  Cankurtaran, M ^a   Tayfur, O ^a   Yavuz, Burcu Balam ^a   Geyik, S ^a   Akhan, O ^a   Arslan, S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; GLUCOSE TOLERANCE; HEPATOMEGALY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; WAIST HIP RATIO;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CHOLESTEROL, HDL; FASTING; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN(A); MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; WAIST-HIP RATIO;

EID: 36048952141     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. LUDWIG J., VIGGIANO T.R., MC GILL D.B., OH B.J. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo. Clin. Proc., 1980, 55 : 434-438.
2. BRUNT E.M., JANNEY C.G., DI BISCEGLIE A.M., NEUSCHWANDERTETRI B.A., BACON B.R. Nonalcoholic steatohepatitis : a proposal for grading and staging the histological lesions. Am. J. Gastroenterol., 1999, 94 : 2467-2474.
3. ANGULO P., KEACH J.C., BATTS K.P., LINDOR K.D. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology, 1999, 30 : 1356-1362.
4. CLARK J.M. Weight Loss as a Treatment for Nonalcoholic Fatty Liver Disease. J. Clin. Gastroenterol., 2006, 40 : S39-S43.
5. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285 : 2486-2497.
6. HARRISON S.A., KADAKIA S., LANG K.A., SCHENKER S. Nonalcoholic steatohepatitis : What we know in the New Millennium. Am. J. Gastroenterol., 2002, 97 : 2714-2724.
7. MARCEAU P., BIRON S., HOULD F.S., MARCEAU S., SIMARD S., THUNG S.N., KRAL J.G. Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab., 1999, 84 : 1513-1517.
8. KNOBLER H., SCHATTNER A., ZHORNICKI T., MALNICK S.D., KETER D., SOKOLOVSKAYA N., LURIE Y., BASS D.D. Fatty liver, an additional and treatable feature of the insulin resistance syndrome. QJM, 1999, 92 : 73-79.
9. CANKURTARAN M., KAV T., YAVUZ B., SHORBAGI A., HALIL M., COSKUN T., ARSLAN S. Serum vitamin-E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels. Acta Gastroenterol. Belg., 2006, 69 : 5-11.
10. DAY C.P. Pathogenesis of steatohepatitis. Best. Pract. Res. Clin. Gastroenterol., 2002, 16 : 663-678.
11. LECLERCQ I.A Pathogenesis of steatohepatitis : insights from the study of animal models. Acta Gastroenterol. Belg., 2007, 70 : 25-31
12. BACON B.R., FARAHVASH M.J., JANNEY C.G. Nonalcoholic steatohepatitis : An expanded clinical entity. Gastroenterology, 1994, 107 : 1103-1109.
13. FARGION S., MATTIOLI M., FRACANZANI A.L. Hyperferritinemia, iron overload, and multiple metabolic alterations identifying patients at risk for nonalcoholic steatohepatitis. Am. J. Gastroenterol., 2001, 96 : 2448-2455.
14. DAY C.P., JAMES O.F. Steatohepatitis : a tale of two "hits"? Gastroenterology, 1998, 114 : 842-845.
15. YOUNOSSI Z.M., GRAMLICH T., BACON B.R., MATTEONI C.A., BOPARAI N., O'NEILL R., MC CULLOUGH A.J. Hepatic iron and non-alcoholic fatty liver disease. Hepatology, 1999, 30 : 847-850.
16. AMERICAN GASTROENTEROLOGICAL ASSOCIATION. Medical position statement : nonalcoholic fatty liver disease. Gastroenterology, 2002, 123 : 1702-1704.
17. NICKLAS B.J., AMBROSIUS W., MESSIER S.P. et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults : a randomized controlled clinical trial. Am. J. Clin. Nutr., 2004, 79 : 544-551.
18. MUSSO G., GAMBINO R., DE MICHIELI F. et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology, 2003, 37 : 909-916.
19. JONHSON D. Current biochemical Studies of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis suggest a new therapeutic approach. Am. J. Gastoenterol., 2003, 98 : 2093-2097.